BB-401
BB-401-01
Phase 2 small_molecule completed
Quick answer
BB-401 for Head and Neck Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Benitec Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Benitec Biopharma
- Indication
- Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed